ClinicalTrials.gov
ClinicalTrials.gov Menu

A Nurse Led Project to Introduce Hand Lettering as a Form of Art Therapy to Patients in an Ambulatory Oncology Setting

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03291730
Recruitment Status : Not yet recruiting
First Posted : September 25, 2017
Last Update Posted : September 25, 2017
Sponsor:
Information provided by (Responsible Party):
Cindy L. Cao, Dana-Farber Cancer Institute

Brief Summary:
The investigators are conducting a project to provide a new type of resource called "hand lettering" to patients receiving chemotherapy. This is a type of art therapy. The goal of this project is to understand if it is feasible to use art-therapy and to describe anxiety before and after completing hand-lettering.

Condition or disease Intervention/treatment Phase
Anxiety Behavioral: Breathing and journaling exercise Other: Art-therapy Not Applicable

Detailed Description:
This study is being done to understand if it is feasible to use a form of art-therapy called hand-lettering at Dana-Farber Cancer Institute. We would also like to explore the anxiety a person has before and after using hand-lettering.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 62 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: A Nurse Led Project to Introduce Hand Lettering as a Form of Art Therapy to Patients in an Ambulatory Oncology Setting
Estimated Study Start Date : October 31, 2017
Estimated Primary Completion Date : October 31, 2020
Estimated Study Completion Date : October 31, 2024

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anxiety

Arm Intervention/treatment
Experimental: Hand Lettering
  • The participant will engage in art-therapy by tracing and coloring a detailed letter or word
  • Participants will also be guided through a relaxation breathing and journaling exercise that can be incorporated into the art activity.
Behavioral: Breathing and journaling exercise
May help reduce anxiety of receiving chemotherapy

Other: Art-therapy
May help reduce anxiety of receiving chemotherapy




Primary Outcome Measures :
  1. Evaluate the feasibility of implementing nurse-led hand-lettering in an ambulatory infusion setting [ Time Frame: 2 years ]
    Feasibility will be defined through enrollment and completion rates.


Secondary Outcome Measures :
  1. Describe patient self-reported anxiety before and after utilizing hand-lettering [ Time Frame: 2 years ]
    Anxiety measured through the State Trait Anxiety Index.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adult patients (>age 18) with a cancer diagnosis receiving oral or IV chemotherapy at Dana-Farber on Yawkey 10.
  • Able to read and speak English
  • Has a minimum appointment time of 60 minutes

Exclusion Criteria:

-Individuals with visual impairment or blindness will be excluded


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03291730


Contacts
Contact: Cindy l. Cao, RN 857-215-1047 cindy_cao@dfci.harvard.edu

Locations
United States, Massachusetts
Dana Farber Cancer Institute Not yet recruiting
Boston, Massachusetts, United States, 02115
Contact: Cindy L. Cao, RN    857-215-1047    cindy_cao@dfci.harvard.edu   
Principal Investigator: Cindy L. Cao, RN         
Sponsors and Collaborators
Dana-Farber Cancer Institute
Investigators
Principal Investigator: Cindy L Cao, RN Dana-Farber Cancer Institute

Responsible Party: Cindy L. Cao, Principal Investigator, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier: NCT03291730     History of Changes
Other Study ID Numbers: 17-377
First Posted: September 25, 2017    Key Record Dates
Last Update Posted: September 25, 2017
Last Verified: September 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Cindy L. Cao, Dana-Farber Cancer Institute:
Anxiety